13F HOLDINGS REPORT (Amended)
Novo Holdings A/S
Quarter ended Q2 2024 · Filed August 20, 2024 · Accession 0000950123-24-008900
Total Value
$1.85B
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VANGUARD INDEX FDS | 922908769 | 1,038,550 | $277.8M | 14.98% |
| 2 | BROOKFIELD CORP | 11271J107 | 3,880,230 | $161.2M | 8.69% |
| 3 | TEMPUS AI INC | TEM | 4,074,419 | $142.6M | 7.69% |
| 4 | ASML HOLDING N V | ASMLF | 133,336 | $136.4M | 7.35% |
| 5 | SALESFORCE INC | CRM | 480,160 | $123.4M | 6.66% |
| 6 | EDGEWISE THERAPEUTICS INC | EWTX | 6,344,430 | $114.3M | 6.16% |
| 7 | CORCEPT THERAPEUTICS INC | CORT | 2,411,362 | $78.3M | 4.22% |
| 8 | VAXCYTE INC | PCVX | 950,000 | $71.7M | 3.87% |
| 9 | INSMED INC | INSM | 800,000 | $53.6M | 2.89% |
| 10 | MIRUM PHARMACEUTICALS INC | MIRM | 1,500,000 | $51.3M | 2.76% |
| 11 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,000,000 | $44.8M | 2.41% |
| 12 | CABLE ONE INC | CABO | 118,403 | $41.9M | 2.26% |
| 13 | BIOMARIN PHARMACEUTICAL INC | BMRN | 490,000 | $40.3M | 2.17% |
| 14 | MERUS N V | N5749R100 | 675,000 | $39.9M | 2.15% |
| 15 | APPLE INC | AAPL | 182,960 | $38.5M | 2.08% |
| 16 | ALIBABA GROUP HLDG LTD | BBAAY | 500,827 | $36.1M | 1.94% |
| 17 | PHARVARIS N V | PHVS | 1,725,000 | $32.4M | 1.75% |
| 18 | CELLDEX THERAPEUTICS INC NEW | CLDX | 850,000 | $31.5M | 1.70% |
| 19 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 1,400,000 | $29.4M | 1.58% |
| 20 | LANZATECH GLOBAL INC | LNZAW | 15,814,845 | $29.3M | 1.58% |
| 21 | ALNYLAM PHARMACEUTICALS INC | ALNY | 118,383 | $28.8M | 1.55% |
| 22 | ARRIVENT BIOPHARMA INC | AVBP | 1,500,000 | $27.8M | 1.50% |
| 23 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,000,000 | $26.0M | 1.40% |
| 24 | CARGO THERAPEUTICS INC | 14179K101 | 1,544,000 | $25.4M | 1.37% |
| 25 | AMICUS THERAPEUTICS INC | FOLD | 2,500,000 | $24.8M | 1.34% |
| 26 | BROOKFIELD ASSET MANAGMT LTD | 113004105 | 627,207 | $23.9M | 1.29% |
| 27 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,100,000 | $23.7M | 1.28% |
| 28 | LEXEO THERAPEUTICS INC | LXEO | 1,450,500 | $23.3M | 1.25% |
| 29 | BLUEPRINT MEDICINES CORP | 09627Y109 | 175,000 | $18.9M | 1.02% |
| 30 | KYVERNA THERAPEUTICS INC | KYTX | 1,750,000 | $13.1M | 0.71% |
| 31 | MORPHIC HLDG INC | 61775R105 | 375,000 | $12.8M | 0.69% |
| 32 | VERVE THERAPEUTICS INC | 92539P101 | 2,400,000 | $11.7M | 0.63% |
| 33 | METAGENOMI INC | MGX | 1,800,000 | $7.3M | 0.40% |
| 34 | IO BIOTECH INC | IOBT | 4,429,449 | $5.2M | 0.28% |
| 35 | ABCELLERA BIOLOGICS INC | ABCL | 1,126,915 | $3.3M | 0.18% |
| 36 | MARQETA INC | MQ | 441,558 | $2.4M | 0.13% |
| 37 | GALECTO INC | 36322Q107 | 2,497,791 | $1.2M | 0.06% |
| 38 | SPERO THERAPEUTICS INC | SPRO | 468,902 | $609,573 | 0.03% |